REALBOTIX CORP

Realbotix secures a $2.5M unsecured bridge loan from Onconetix to support its merger, providing interest‑free liquidity that eases integration and preserves balance‑sheet strength.

Realbotix Corp: TSX Venture Exchange stock, P/E -5.07, volatile yet poised for growth through blockchain‑powered tokenization and digital asset solutions.

Realbotix Corp’s TSX Venture stock swings, negative P/E and ties to Tokens.com highlight its role in Canada’s growing blockchain‑powered capital markets.

Realbotix Corp’s latest move: acquisition of Onconetix, a negative P/E and CAD 0.295 share price—how the firm plans to grow in the digital‑asset, blockchain sector.

Realbotix Corp’s CES 2026 demo shows fully autonomous humanoid robots with real‑time local AI, lip‑syncing and bi‑directional conversation, positioning the company for retail, hospitality, and healthcare deployments.

Realbotix Corp. partners with The FUTR Corporation to merge AI‑powered humanoid robots with privacy‑first AI agents, unlocking secure, token‑enabled real‑world interactions.

Realbotix Corp’s TSX Venture woes: a falling price, negative P/E, and the urgent need for a turnaround plan amid a digital‑economy shift.

Realbotix Corp’s volatile TSX Venture stock and negative P/E signal investor concern as the Vancouver‑based tokenization firm seeks to prove long‑term viability in Canada’s competitive blockchain market.

Realbotix Corp, a Vancouver‑based fintech on TSX Venture, pioneers blockchain tokenization, helping Canadian businesses issue digital assets for a more efficient, interconnected economy.

Realbotix Corp reports a 166% increase in Q2-2025 financial metrics, exceeding analyst expectations, driven by a strategic partnership and strong revenue growth in the AI-powered humanoid robot market.